DE68911132D1 - Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils. - Google Patents
Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.Info
- Publication number
- DE68911132D1 DE68911132D1 DE89905016T DE68911132T DE68911132D1 DE 68911132 D1 DE68911132 D1 DE 68911132D1 DE 89905016 T DE89905016 T DE 89905016T DE 68911132 T DE68911132 T DE 68911132T DE 68911132 D1 DE68911132 D1 DE 68911132D1
- Authority
- DE
- Germany
- Prior art keywords
- cholesterin
- lipoprotein
- profile
- improving
- stimulating factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/170,478 US5019381A (en) | 1988-03-21 | 1988-03-21 | Method for lowering cholesterol levels using GM-CSF |
US07/281,432 US5021239A (en) | 1988-03-21 | 1988-12-08 | Use of M-CSF to improve lipoprotein cholesterol profiles |
PCT/US1989/001137 WO1989009060A1 (en) | 1988-03-21 | 1989-03-20 | Hematopoietic colony-stimulating factors improve the lipoprotein cholesterol profile |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68911132D1 true DE68911132D1 (de) | 1994-01-13 |
DE68911132T2 DE68911132T2 (de) | 1994-03-31 |
Family
ID=26866124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE89905016T Expired - Fee Related DE68911132T2 (de) | 1988-03-21 | 1989-03-20 | Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5021239A (de) |
EP (1) | EP0406324B1 (de) |
JP (1) | JPH0678240B2 (de) |
KR (1) | KR970009891B1 (de) |
AU (1) | AU624612B2 (de) |
DE (1) | DE68911132T2 (de) |
WO (1) | WO1989009060A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
US5290549A (en) * | 1988-03-21 | 1994-03-01 | Genetics Institute, Inc.-Legal Affairs | Method for reducing atherosclerotic lesions in a mammal |
US5288487A (en) * | 1989-02-28 | 1994-02-22 | Morinaga Milk Industry Co., Ltd. | Human monocyte-macrophage-CSF preparations |
DE69022606T2 (de) * | 1989-02-28 | 1996-05-02 | Morinaga Milk Industry Co Ltd | Menschlichen Monozyt-Makrophagen-Koloniestimulierungsfaktor enthaltende Zusammensetzung. |
JP2641067B2 (ja) * | 1989-05-12 | 1997-08-13 | 森永乳業株式会社 | 高脂血症治療剤 |
JPH082796B2 (ja) * | 1989-04-04 | 1996-01-17 | 森永乳業株式会社 | 高脂血症治療剤 |
US5714140A (en) * | 1989-12-13 | 1998-02-03 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting the production of bioactive IL-1 by administering M-CSF |
EP0456842B1 (de) * | 1989-12-13 | 1996-03-20 | Otsuka Pharmaceutical Co., Ltd. | Medizinische verwendung von m-csf |
US5385731A (en) * | 1991-11-14 | 1995-01-31 | Montefiore Medical Center | Method of treating hyperlipidemia with granulocyte colony stimulating factor |
US7247618B2 (en) * | 2001-04-30 | 2007-07-24 | Tripathi Rajavashisth | Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
-
1988
- 1988-12-08 US US07/281,432 patent/US5021239A/en not_active Expired - Fee Related
-
1989
- 1989-03-20 DE DE89905016T patent/DE68911132T2/de not_active Expired - Fee Related
- 1989-03-20 AU AU34416/89A patent/AU624612B2/en not_active Ceased
- 1989-03-20 EP EP89905016A patent/EP0406324B1/de not_active Expired - Lifetime
- 1989-03-20 JP JP1504695A patent/JPH0678240B2/ja not_active Expired - Lifetime
- 1989-03-20 WO PCT/US1989/001137 patent/WO1989009060A1/en active IP Right Grant
- 1989-11-20 KR KR89702153A patent/KR970009891B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE68911132T2 (de) | 1994-03-31 |
KR900700123A (ko) | 1990-08-11 |
JPH0678240B2 (ja) | 1994-10-05 |
AU624612B2 (en) | 1992-06-18 |
EP0406324A1 (de) | 1991-01-09 |
KR970009891B1 (en) | 1997-06-19 |
AU3441689A (en) | 1989-10-16 |
WO1989009060A1 (en) | 1989-10-05 |
EP0406324B1 (de) | 1993-12-01 |
JPH03503418A (ja) | 1991-08-01 |
US5021239A (en) | 1991-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA227794A (de) | Beschlag zur höhenverstellung von schubladen | |
DE69026081D1 (de) | Subkutane Elektroden zur Entflimmerung | |
MY104685A (en) | Substituted thiazoles and their use as fungicides. | |
FI883238L (fi) | Mikrobicid komposition. | |
DE3786252D1 (de) | Gummi-zusammensetzung. | |
DE3874313D1 (de) | Kautschukzusammensetzung. | |
FI883327A0 (fi) | Fordonsaktig sjaelvgaoende arbetsplattform med laog profil foer arbeten ovan jord. | |
DE59007513D1 (de) | Anordnung zur Gewebestimulation. | |
DE59008148D1 (de) | Anordnung zur Gewebestimulation. | |
DE68911132D1 (de) | Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils. | |
ZA884838B (en) | Dopamine-beta-hydroxylase inhibitors | |
DE3881783D1 (de) | Zahnbuerste zur regelung des buerstenrhythmus. | |
FI880158A0 (fi) | Diuretisk komposition. | |
DE3865417D1 (de) | Vinylester-latizes. | |
DE69111768D1 (de) | Enzymatische Zusammensetzung zur Bestimmung von Äthanol. | |
ZA883851B (en) | Dopamine-beta-hydroxylase inhibitors | |
DE3854179D1 (de) | Vulkanisierbare Fluorkautschukzusammensetzung. | |
NO883582D0 (no) | Katodisk elektrodeponerbart belegningspreparat. | |
DK159088A (da) | Overfladebehandlingskompostition | |
FI905815A0 (fi) | Kompositioner med kontrollerad frigoerning. | |
ZA889709B (en) | Dopamine-beta-hydroxylase inhibitors | |
DE3783693D1 (de) | Verfahren zur reinigung des gewebeplasminogenaktivators. | |
DE58901714D1 (de) | Verfahren zur verbesserung des nordungsergebnisses. | |
PT86513A (en) | Dopamine-beta-hydroxylase inhibitors | |
DE68913995D1 (de) | Zusammensetzung zur behandlung progressiver myopie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |